Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bingduning
- Development stage
- Unknown
- Lead developer
- Guangzhou University of Chinese Medicine Tropical Medicine Research Institute
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Bingduning is a botanical extract preparation developed by the Guangzhou University of Chinese Medicine Tropical Medicine Research Institute. It is primarily investigated for the treatment of the common cold, specifically targeting the wind-heat syndrome in Traditional Chinese Medicine (TCM). The drug is formulated as drops and has been evaluated in Phase II clinical trials to assess its efficacy, safety, and potential antiviral properties against respiratory infections. As a TCM-derived product, it likely contains multiple active components intended to alleviate symptoms such as fever, sore throat, and cough associated with viral upper respiratory tract infections.
- Brand names
- Bingduning
- Other names
- Bingduning Drops
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))NeuraminidaseIL-6 (Interleukin 6)
Beyond the preview
Go deeper on Bingduning.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bingduning.